검색
Q32 Bio Inc
QTTB관심 목록에 추가
9.220USD
-0.340-3.56%
종가 09-24 16:00（ET）
274.39M시가총액
3.30P/E TTM
Q32 Bio Inc 정보 회사
Q32 Bio Inc. is a clinical-stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity in autoimmune and inflammatory diseases. It focuses on developing novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. Bempikibart (ADX-914), its advanced product candidate, is a fully human anti-interleukin-7 receptor alpha (IL-7Rα), an antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 (IL-7), and thymic stromal lymphopoietin (TSLP). It has completed two Phase IIa clinical trials evaluating bempikibart, SIGNAL-AA for the treatment of alopecia areata (AA), and SIGNAL-AD for the treatment of atopic dermatitis (AD). ADX-097, a Phase 2 asset and the lead product candidate from its complement inhibitor platform, is a humanized anti-C3d monoclonal antibody, fusion protein.
Q32 Bio Inc 프로필
종목 코드 QTTB
회사 이름Q32 Bio Inc
상장일Mar 28, 2018
CEOMorrison (Jodie Pope)
직원 수42
유형Ordinary Share
회계 연도 종료Mar 28
주소830 Winter Street
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02451
전화17819990232
웹사이트https://www.q32bio.com/
종목 코드 QTTB
상장일Mar 28, 2018
CEOMorrison (Jodie Pope)
Q32 Bio Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Arthur O. Tzianabos, Ph.D.
Dr. Arthur O. Tzianabos, Ph.D.
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
자주 묻는 질문
Q32 Bio Inc의 상위 5대 주주는 누구인가요?
Q32 Bio Inc의 상위 5대 주주는 다음과 같습니다: Ms. Jodie Pope Morrison
Q32 Bio Inc(QTTB)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Q32 Bio Inc의 주식을 보유한 기관은 총 189곳이며, 이들이 보유한 주식의 총 가치는 약 9.99M로 전체 발행 주식의 65.09%를 차지합니다. 이는 2025Q4 대비 -2048479.00 증가한 수치입니다.